Drug · MS · S1P · MS · S1P · Verified drug
Siponimod (Mayzent) structure · mechanism
Siponimod (Mayzent) 2D structure
- Role
- Drug
- Family
- MS S1P modulator series
- Mechanism class
- MS · S1P
- Parent scaffold
- Sphingosine-like pharmacophore
- Indication
- Secondary progressive MS · FDA/EMA
- Structure source
- Catalog seed
- FDA / EMA
- FDA/EMA
- ClinicalTrials.gov
- siponimod MS
- Regulatory status
- Approved · FDA/EMA · ClinicalTrials.gov · ClinicalTrials.gov
SMILES
CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)OTags
Related compounds
External IDs · BioMoa
StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.